Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,917 | 8,570 | 9,390 | 10,070 | 1,850 |
| Marketable Securities | 535 | 510 | 510 | 530 | 0 |
| Receivables | 606 | 370 | 400 | 200 | 750 |
| Other current assets | 0 | 10 | 10 | 0 | 10 |
| TOTAL | $9,058 | $9,460 | $10,310 | $10,800 | $2,610 |
| Non-Current Assets | |||||
| PPE Net | 505 | 1,700 | N/A | N/A | N/A |
| Investments And Advances | 544 | 520 | 520 | 540 | 510 |
| Other Non-Current Assets | 77 | 70 | 6 | 70 | 350 |
| TOTAL | $1,126 | $2,290 | $526 | $610 | $860 |
| Total Assets | $10,184 | $10,580 | $11,400 | $12,050 | $4,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 417 | 230 | 140 | 160 | 190 |
| Other current liabilities | N/A | 190 | 190 | 210 | 210 |
| TOTAL | $417 | $430 | $340 | $380 | $410 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,224 | 1,550 | 1,760 | 2,120 | 10 |
| TOTAL | $1,224 | $1,550 | $1,760 | $2,120 | $10 |
| Total Liabilities | $1,641 | $1,990 | $2,100 | $2,510 | $420 |
| Shareholders' Equity | |||||
| Retained earnings | -21,630 | -20,420 | -19,470 | -20,310 | 4 |
| Other shareholders' equity | 677 | 650 | 650 | 680 | -17,294 |
| TOTAL | $8,543 | $8,590 | $9,300 | $9,530 | $3,680 |
| Total Liabilities And Equity | $10,184 | $10,580 | $11,400 | $12,040 | $4,100 |